As capital sources become more elusive, companies are increasingly exploring creative methods to structure transactions and it is more important than ever to find successful transaction structures that build value. This session will focus on unique financial structures that have been utilized to leverage industry and financing opportunities.
This panel will review the following:
Combined deferred mergers and product development licenses
Debt transactions
Equity lines
The use of business incubators
Moderator:
- Richard A. Kaufman, Partner, Foley & Lardner
Panelists:
- Mark Benedyk, Head of The Pfizer Incubator LLC
- Donna Tempel, Ph.D., President and CEO, Drais Pharmaceuticals
- Jack Lief, Co-Founder, Chairman, President & CEO, Arena Pharmaceuticals
- Michael White, Deal Team Leader, Silicon Valley Bank
Related Insights
August 5, 2025
Foley Viewpoints
Virginia Bureau of Insurance Issues Updated Guidance Regarding Minimum Capital and Surplus, Seasoning, and Procedures for Companies Seeking to be Licensed as Insurers
On August 6, the Virginia Bureau of Insurance (BOI) issued Administrative Letter 2025-03 (the Letter)[1] to all companies seeking to be…
August 4, 2025
Energy Current
The Shifting Winds in Federal Energy Policy: Department of the Interior Implements Sweeping New Review Requirements for Wind and Solar Energy Projects
On July 15, 2025, the U.S. Department of the Interior (DOI) issued a memorandum establishing significantly heightened review procedures…
August 4, 2025
Foley Viewpoints
Virginia Bureau of Insurance Issues Guidance Clarifying Material Change and Required Notifications for Managed Care Health Insurance Plans
On July 22, the Virginia Bureau of Insurance (BOI) issued Administrative Letter 2025-02 (the Letter) to all managed care health insurance…